Figures computed from official regulatory filings — .
Ownershipinsiders 57.5% · institutions 0.1%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Darwin AG only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Novogenia AG manufactures and sells personalized health products in global markets. The company offers products, such as personalized supplements and cosmetics; and services, including genetic testing, advanced therapies like personalized infusion therapies and reproductive genetics, and contract manufacturing. The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany.
Market information source · Oct 19, 2026
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Matthias Probst | Sell | $138.9K | BAFIN |
| Michael Huttegger | Sell | $138.9K | BAFIN |